COMPANY WORKBOOK · VRTX

Vertex Pharmaceuticals Incorporated

Healthcare & Life Sciences · N/A

$547.09+0.85%

70/100

Overall

MARKET CAP138.71B

FORWARD P/E27.47

PEG RATION/A

REVENUE GROWTHN/A

OPERATING MARGINN/A

52W RANGE$409.47 – $558.88

INTERACTIVE PRICE CHART

Trend and moving averages

RELATIVE PERFORMANCE

Indexed to 100

LIVE MODEL SCORE

Momentum80

Technicals83

Fundamentals61

Thematic Fit55

Scores are percentile-ranked against the current Young Bull universe and stored by date in PostgreSQL.

YOUNG BULL THESIS

This company is available as a market-data workbook. Young Bull has not added a manual investment thesis for it yet.

MODEL READ

Overall score: 69.9. Last ranked 2026-11-07.

QUARTERLY FUNDAMENTALS

TRAILING P/E35.21

PRICE / SALESN/A

EV / EBITDAN/A

BOOK VALUEN/A

GROSS MARGINN/A

PROFIT MARGINN/A

RETURN ON EQUITYN/A

FREE CASH FLOWN/A

COMPANY SNAPSHOT

Description unavailable.

PRIMARY SOURCES